{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:02:00Z","timestamp":1794258120303,"version":"4.9.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2023YFF1000904"],"award-info":[{"award-number":["2023YFF1000904"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32372970"],"award-info":[{"award-number":["32372970"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Type 1 diabetes (T1D) results from the destruction of pancreatic \u03b2-cells, leading to insulin deficiency. As insulin therapy does not affect disease progression, advancements in immune regulation therapies have emerged, including the reconstitution of the insulin secretory system. Cysteine-rich acidic secretory protein (\n                      <jats:italic>SPARC<\/jats:italic>\n                      ) is an extracellular matrix glycoprotein that regulates cell adhesion, facilitating cell migration, and mediating interactions between cells and their extracellular matrix.\n                      <jats:italic>SPARC<\/jats:italic>\n                      is overexpressed during tissue repair and is involved in \u03b2-cells survival. However, the potential of\n                      <jats:italic>SPARC<\/jats:italic>\n                      -modified mesenchymal stem cells (MSCs) to improve insulin secretion has not been thoroughly investigated. This study investigated the therapeutic effects of\n                      <jats:italic>SPARC<\/jats:italic>\n                      -MSCs in vivo and in vitro and assessed whether\n                      <jats:italic>SPARC<\/jats:italic>\n                      enhances survival and insulin secretion after \u03b2-cells injury.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In vivo, we established T1D models in mice and canine using\n                      <jats:italic>SPARC<\/jats:italic>\n                      -MSCs for cell transplantation. In vitro, MIN6 cells were damaged with STZ, and\n                      <jats:italic>SPARC<\/jats:italic>\n                      -MSC supernatant was co-cultured with MIN6 for various assays.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our study demonstrated that\n                      <jats:italic>SPARC<\/jats:italic>\n                      enhanced the regenerative capacity and migratory efficiency of MSCs after H\n                      <jats:sub>2<\/jats:sub>\n                      O\n                      <jats:sub>2<\/jats:sub>\n                      injury and improved their morphology. In STZ-induced canine and mice diabetes models,\n                      <jats:italic>SPARC<\/jats:italic>\n                      -MSCs therapy significantly reduced hyperglycemia, improved oral glucose tolerance test (OGTT), and reversed weight loss in canine. Biochemical analyses showed improved liver function, and histological examination revealed restored islet area was significantly restored. Transcriptome and proteome sequencing indicated significant enrichment in calcium binding and cell migration pathways. Co-culturing\n                      <jats:italic>SPARC<\/jats:italic>\n                      -MSC supernatant with MIN6 cells after STZ injury restored their regenerative ability, enhancing insulin secretion and ATP content under high glucose stimulation.\n                      <jats:italic>SPARC<\/jats:italic>\n                      treatment also significantly increased intracellular Ca\n                      <jats:sup>2+<\/jats:sup>\n                      levels in MIN6 cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:italic>SPARC<\/jats:italic>\n                      significantly promotes cell regeneration and stimulates insulin secretion by increasing intracellular ATP and Ca\n                      <jats:sup>2+<\/jats:sup>\n                      influx. In diabetic canine and mice models, it alleviated hyperglycemia, improved glucose tolerance, and enhanced pancreatic islet area and insulin secretion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-025-04727-2","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:40:35Z","timestamp":1762162835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["SPARC-modified mesenchymal stem cells promote recovery of \u03b2-cells and insulin secretion by calcium ion homeostasis"],"prefix":"10.1186","volume":"16","author":[{"given":"Jiaqi","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkai","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Merzlikin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixi","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydmila","family":"Gerunova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changrong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9788-8592","authenticated-orcid":false,"given":"Jinlian","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"4727_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2337\/dc11-S062","volume":"34","author":"Diagnosis and classification of diabetes mellitus","year":"2011","unstructured":"Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34:62\u20139.","journal-title":"Diabetes Care"},{"issue":"585","key":"4727_CR2","first-page":"600","volume":"20","author":"V Mohammadi","year":"2024","unstructured":"Mohammadi V, Maleki AJ, Nazari M, Siahmansouri A, Moradi A, Elahi R, et al. Chimeric antigen receptor (CAR)-based cell therapy for type 1 diabetes mellitus (T1DM); current progress and future approaches. Stem Cell Rev Rep. 2024;20(585):600.","journal-title":"Stem Cell Rev Rep."},{"issue":"217","key":"4727_CR3","first-page":"240","volume":"22","author":"F Boscari","year":"2021","unstructured":"Boscari F, Avogaro A. Current treatment options and challenges in patients with Type 1 diabetes: pharmacological, technical advances and future perspectives. Rev Endocr Metab Disord. 2021;22(217):240.","journal-title":"Rev Endocr Metab Disord"},{"issue":"715","key":"4727_CR4","first-page":"725","volume":"17","author":"C Mathieu","year":"2021","unstructured":"Mathieu C, Martens P-J, Vangoitsenhoven R. One hundred years of insulin therapy. Nat Rev Endocrinol. 2021;17(715):725.","journal-title":"Nat Rev Endocrinol"},{"key":"4727_CR5","doi-asserted-by":"publisher","first-page":"102289","DOI":"10.1016\/j.jaut.2019.05.017","volume":"103","author":"M Tenspolde","year":"2019","unstructured":"Tenspolde M, Zimmermann K, Weber LC, Hapke M, Lieber M, Dywicki J, et al. Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes. J Autoimmun. 2019;103:102289.","journal-title":"J Autoimmun"},{"issue":"83","key":"4727_CR6","first-page":"91","volume":"139","author":"Q Ni","year":"2019","unstructured":"Ni Q, Pham NB, Meng WS, Zhu G, Chen X. Advances in immunotherapy of type I diabetes. Adv Drug Deliv Rev. 2019;139(83):91.","journal-title":"Adv Drug Deliv Rev"},{"issue":"530","key":"4727_CR7","first-page":"548","volume":"30","author":"NJ Hogrebe","year":"2023","unstructured":"Hogrebe NJ, Ishahak M, Millman JR. Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes. Cell Stem Cell. 2023;30(530):548.","journal-title":"Cell Stem Cell"},{"key":"4727_CR8","doi-asserted-by":"publisher","first-page":"1389134","DOI":"10.3389\/fimmu.2024.1389134","volume":"15","author":"L Mou","year":"2024","unstructured":"Mou L, Wang TB, Wang X, Pu Z. Advancing diabetes treatment: the role of mesenchymal stem cells in islet transplantation. Front Immunol. 2024;15:1389134.","journal-title":"Front Immunol"},{"issue":"108","key":"4727_CR9","first-page":"1897","volume":"2023","author":"A Mik\u0142osz","year":"1889","unstructured":"Mik\u0142osz A, Chabowski A. Adipose-derived mesenchymal stem cells therapy as a new treatment option for diabetes mellitus. J Clin Endocrinol Metab. 1889;2023(108):1897.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2534","key":"4727_CR10","first-page":"2545","volume":"61","author":"\u00caJ Bassi","year":"2012","unstructured":"Bassi \u00caJ, Moraes-Vieira PMM, Moreira-S\u00e1 CSR, Almeida DC, Vieira LM, Cunha CS, et al. Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes. Diabetes. 2012;61(2534):2545.","journal-title":"Diabetes"},{"key":"4727_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-022-00932-0","volume":"7","author":"Y Han","year":"2022","unstructured":"Han Y, Yang J, Fang J, Zhou Y, Candi E, Wang J, et al. The secretion profile of mesenchymal stem cells and potential applications in treating human diseases. Signal Transduct Target Ther. 2022;7:92.","journal-title":"Signal Transduct Target Ther"},{"key":"4727_CR12","doi-asserted-by":"publisher","first-page":"8614","DOI":"10.1126\/sciadv.abn8614","volume":"8","author":"TT Nguyen","year":"2022","unstructured":"Nguyen TT, Pham D-V, Park J, Phung CD, Nepal MR, Pandit M, et al. Engineering of hybrid spheroids of mesenchymal stem cells and drug depots for immunomodulating effect in islet xenotransplantation. Sci Adv. 2022;8:8614.","journal-title":"Sci Adv"},{"key":"4727_CR13","doi-asserted-by":"publisher","first-page":"963689721107312","DOI":"10.1177\/09636897211073127","volume":"31","author":"L Wei","year":"2022","unstructured":"Wei L, Zhang L, Yang L, Wang X, Zhao C, Zhao D. Protective effect of mesenchymal stem cells on isolated islets survival and against hypoxia associated with the HIF-1\u03b1\/PFKFB3 pathway. Cell Transplant. 2022;31:9636897211073128.","journal-title":"Cell Transplant"},{"issue":"915","key":"4727_CR14","first-page":"929","volume":"14","author":"J Song","year":"2023","unstructured":"Song J, Liu J, Cui C, Hu H, Zang N, Yang M, et al. Mesenchymal stromal cells ameliorate diabetes-induced muscle atrophy through exosomes by enhancing AMPK\/ULK1-mediated autophagy. J Cachexia Sarcopenia Muscle. 2023;14(915):929.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"23","key":"4727_CR15","first-page":"5428","volume":"101","author":"S Jiang","year":"2023","unstructured":"Jiang S, Sun H-F, Li S, Zhang N, Chen J-S, Liu J-X. SPARC: a potential target for functional nanomaterials and drugs. Front Mol Biosci. 2023;101(23):5428.","journal-title":"Front Mol Biosci"},{"issue":"816","key":"4727_CR16","first-page":"827","volume":"19","author":"RA Brekken","year":"2001","unstructured":"Brekken RA, Sage EH. SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol. 2001;19(816):827.","journal-title":"Matrix Biol"},{"issue":"815","key":"4727_CR17","first-page":"831","volume":"79","author":"C Atorrasagasti","year":"2023","unstructured":"Atorrasagasti C, Onorato AM, Mazzolini G. The role of SPARC (secreted protein acidic and rich in cysteine) in the pathogenesis of obesity, type 2 diabetes, and non-alcoholic fatty liver disease. J Physiol Biochem. 2023;79(815):831.","journal-title":"J Physiol Biochem"},{"issue":"25","key":"4727_CR18","first-page":"235","volume":"62","author":"K Kos","year":"2010","unstructured":"Kos K, Wilding JPH. SPARC: a key player in the pathologies associated with obesity and diabetes. Nat Rev Endocrinol. 2010;62(25):235.","journal-title":"Nat Rev Endocrinol"},{"issue":"15","key":"4727_CR19","doi-asserted-by":"publisher","first-page":"12179","DOI":"10.3390\/ijms241512179","volume":"24","author":"SM Ham","year":"2023","unstructured":"Ham SM, Song MJ, Yoon H-S, Lee DH, Chung JH, Lee S-T. SPARC is highly expressed in young skin and promotes extracellular matrix integrity in fibroblasts via the TGF-\u03b2 signaling pathway. Int J Mol Sci. 2023;24(15):12179.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4727_CR20","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.immuni.2022.07.007","volume":"55","author":"S Ryu","year":"2022","unstructured":"Ryu S, Sidorov S, Ravussin E, Artyomov M, Iwasaki A, Wang A, et al. The matricellular protein SPARC induces inflammatory interferon-response in macrophages during aging. Immunity. 2022;55(9):1609.","journal-title":"Immunity"},{"issue":"67","key":"4727_CR21","first-page":"76","volume":"21","author":"AS Llera","year":"2010","unstructured":"Llera AS, Girotti MR, Benedetti LG, Podhajcer OL. Matricellular proteins and inflammatory cells: a task force to promote or defeat cancer? Cytokine Growth Factor Rev. 2010;21(67):76.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"13","key":"4727_CR22","doi-asserted-by":"publisher","first-page":"6173","DOI":"10.7150\/thno.58254","volume":"11","author":"LB Alcaraz","year":"2021","unstructured":"Alcaraz LB, Mallavialle A, David T, Derocq D, Delolme F, Dieryckx C, et al. A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment. Theranostics. 2021;11(13):6173.","journal-title":"Theranostics"},{"issue":"2","key":"4727_CR23","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1074\/jbc.M808285200","volume":"284","author":"J Nie","year":"2009","unstructured":"Nie J, Sage EH. SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling. J Biol Chem. 2009;284(2):1279.","journal-title":"J Biol Chem"},{"key":"4727_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068253","volume":"8","author":"LW Harries","year":"2013","unstructured":"Harries LW, McCulloch LJ, Holley JE, Rawling TJ, Welters HJ, Kos K. A role for SPARC in the moderation of human insulin secretion. PLoS ONE. 2013;8:e68253.","journal-title":"PLoS ONE"},{"issue":"2","key":"4727_CR25","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1042\/CS20180714","volume":"133","author":"C Atorrasagasti","year":"2019","unstructured":"Atorrasagasti C, Onorato A, Gimeno ML, Andreone L, Garcia M, Malvicini M, et al. SPARC is required for the maintenance of glucose homeostasis and insulin secretion in mice. Clin Sci (Lond). 2019;133(2):351.","journal-title":"Clin Sci (Lond)"},{"issue":"17","key":"4727_CR26","first-page":"581","volume":"10","author":"L Hu","year":"2020","unstructured":"Hu L, He F, Huang M, Zhao Q, Cheng L, Said N, et al. SPARC promotes insulin secretion through down-regulation of RGS4 protein in pancreatic \u03b2 cells. Sci Rep. 2020;10(17):581.","journal-title":"Sci Rep"},{"issue":"25","key":"4727_CR27","first-page":"26","volume":"15","author":"L Kong","year":"2024","unstructured":"Kong L, Zhao Q, Jiang X, Hu J, Jiang Q, Sheng L, et al. Trimethylamine N-oxide impairs \u03b2-cell function and glucose tolerance. Nat Commun. 2024;15(25):26.","journal-title":"Nat Commun"},{"issue":"21","key":"4727_CR28","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1111\/bph.16160","volume":"180","author":"HT Nguyen","year":"2023","unstructured":"Nguyen HT, Noriega Polo C, Wiederkehr A, Wollheim CB, Park K-S. CDN1163, an activator of sarco\/endoplasmic reticulum Ca2+ ATPase, up-regulates mitochondrial functions and protects against lipotoxicity in pancreatic \u03b2-cells. Br J Pharmacol. 2023;180(21):2762.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"4727_CR29","doi-asserted-by":"publisher","first-page":"452","DOI":"10.2337\/diabetes.54.2.452","volume":"54","author":"AK Cardozo","year":"2005","unstructured":"Cardozo AK, Ortis F, Storling J, Feng Y-M, Rasschaert J, Tonnesen M, et al. Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells. Diabetes. 2005;54(2):452.","journal-title":"Diabetes"},{"issue":"9","key":"4727_CR30","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.2337\/db18-1112","volume":"68","author":"F Dingreville","year":"2019","unstructured":"Dingreville F, Panthu B, Thivolet C, Ducreux S, Gouriou Y, Pesenti S, et al. Differential effect of glucose on ER-mitochondria Ca2+ exchange participates in insulin secretion and glucotoxicity-mediated dysfunction of \u03b2-Cells. Diabetes. 2019;68(9):1778\u201394.","journal-title":"Diabetes"},{"issue":"11","key":"4727_CR31","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1172\/JCI119071","volume":"98","author":"ED Kennedy","year":"1996","unstructured":"Kennedy ED, Rizzuto R, Theler JM, Pralong WF, Bastianutto C, Pozzan T, et al. Glucose-stimulated insulin secretion correlates with changes in mitochondrial and cytosolic Ca2+ in aequorin-expressing INS-1 cells. J Clin Invest. 1996;98(11):2524.","journal-title":"J Clin Invest"},{"issue":"44","key":"4727_CR32","doi-asserted-by":"publisher","first-page":"30614","DOI":"10.1074\/jbc.M114.573980","volume":"289","author":"CL Ryall","year":"2014","unstructured":"Ryall CL, Viloria K, Lhaf F, Walker AJ, King A, Jones P, et al. Novel role for matricellular proteins in the regulation of islet \u03b2 cell survival: the effect of SPARC on survival, proliferation, and signaling. J Biol Chem. 2014;289(44):30614.","journal-title":"J Biol Chem"},{"issue":"3","key":"4727_CR33","first-page":"70","volume":"13","author":"P Dai","year":"2022","unstructured":"Dai P, Qi G, Xu H, Zhu M, Li J, Chen Y, et al. Reprogramming adipose mesenchymal stem cells into islet \u03b2-cells for the treatment of canine diabetes mellitus. Stem Cell Res Ther. 2022;13(3):70.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4727_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13287-024-03815-z","volume":"15","author":"C Li","year":"2024","unstructured":"Li C, Li B, Han M, Tian H, Gao J, Han D, et al. SPARC overexpression in allogeneic adipose-derived mesenchymal stem cells in dog dry eye model induced by benzalkonium chloride. Stem Cell Res Ther. 2024;15(1):195.","journal-title":"Stem Cell Res Ther"},{"key":"4727_CR35","first-page":"511","volume":"49503","author":"Y Wei","year":"2016","unstructured":"Wei Y, Fang J, Cai S, Lv C, Zhang S, Hua J. Primordial germ cell-like cells derived from canine adipose mesenchymal stem cells. Cell Prolif. 2016;49503:511.","journal-title":"Cell Prolif"},{"key":"4727_CR36","first-page":"521","volume":"44505","author":"M-F Zhang","year":"2023","unstructured":"Zhang M-F, Wan S-C, Chen W-B, Yang D-H, Liu W-Q, Li B-L, et al. Transcription factor Dmrt1 triggers the SPRY1-NF-\u03baB pathway to maintain testicular immune homeostasis and male fertility. Zool Res. 2023;44505:521.","journal-title":"Zool Res"},{"key":"4727_CR37","doi-asserted-by":"publisher","first-page":"132226","DOI":"10.1016\/j.ijbiomac.2024.132226","volume":"270","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Yang B, Sun W, Sun X, Zhao J, Li Q. Structural characterization of squash polysaccharide and its effect on STZ-induced diabetes mellitus model in MIN6 cells. Int J Biol Macromol. 2024;270:132226.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"4727_CR38","first-page":"3554","volume":"24","author":"L Li","year":"2023","unstructured":"Li L, Dai Y, Ke D, Liu J, Chen P, Wei D, et al. Ferroptosis: new insight into the mechanisms of diabetic nephropathy and retinopathy. Front Endocrinol (Lausanne). 2023;24(4):3554.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4727_CR39","first-page":"531","volume":"49517","author":"J Refardt","year":"2020","unstructured":"Refardt J, Winzeler B, Christ-Crain M. Diabetes insipidus: an update. Endocrinol Metab Clin North Am. 2020;49517:531.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"4727_CR40","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.3390\/ijms24043554","volume":"24","author":"R Galiero","year":"2023","unstructured":"Galiero R, Caturano A, Vetrano E, Beccia D, Brin C, Alfano M, et al. Peripheral neuropathy in diabetes mellitus: pathogenetic mechanisms and diagnostic options. Int J Mol Sci. 2023;24(4):3554.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4727_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4093\/dmj.2018.0259","volume":"43","author":"V Spallone","year":"2019","unstructured":"Spallone V. Update on the impact, diagnosis and management of cardiovascular autonomic neuropathy in diabetes: what is defined, what is new, and what is unmet. Diabetes Metab J. 2019;43(1):3.","journal-title":"Diabetes Metab J"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04727-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04727-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04727-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T11:08:01Z","timestamp":1762168081000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04727-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4727"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04727-2","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study of \u201c\n                      SPARC\n                      -modified Mesenchymal Stem Cells Promote Recovery of \u03b2-cells and Insulin Secretion by Calcium Ion Homeostasis\u201d was approved by the Northwest A&F University Animal Care and Use Ethics Committee on Nov.09, 2024, with approval number IACUC 2024-1109. The study of \u201cEstablish of MSCs and SPARC-MSCs\u201d was approved by the Northwest A&F University Animal Care and Use Ethics Committee on Feb.20, 2023, with approval number NWAFU.No20234580d0600601.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"607"}}